Clinical Trial Update: A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

This clinical trial is evaluating two Pfizer investigational medicines (PF-07275315 and PF-07264660) for moderate to severe atopic dermatitis in Phase 2, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PF-07264660
• PF-07275315 (PF-07275315)

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING